Schechter MT - Search Results

1

Barriers to use of free antiretroviral therapy in injection drug users.

Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, Schechter MT, Hogg RS. Strathdee SA, et al. Among authors: schechter mt. JAMA. 1998 Aug 12;280(6):547-9. doi: 10.1001/jama.280.6.547. JAMA. 1998. PMID: 9707146

2

Lower socioeconomic status and shorter survival following HIV infection.

Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT. Hogg RS, et al. Among authors: schechter mt. Lancet. 1994 Oct 22;344(8930):1120-4. doi: 10.1016/s0140-6736(94)90631-9. Lancet. 1994. PMID: 7934494

3

Impact of HIV infection and AIDS on death rates in British Columbia and Canada.

Hogg RS, Schechter MT, Montaner JS, Goldstone I, Craib K, O'Shaughnessy MV. Hogg RS, et al. Among authors: schechter mt. CMAJ. 1994 Mar 1;150(5):711-7. CMAJ. 1994. PMID: 8313290 Free PMC article.

4

Should we embrace new drugs with open arms? Experience from a community-based, open-arm, randomized clinical trial of combination antiretroviral therapy in advanced HIV disease.

Montaner JS, Hogg R, Srour LF, Murphy C, Barber CG, Phillips P, O'Shaughnessy M, Schechter MT. Montaner JS, et al. Among authors: schechter mt. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15;13(5):422-6. doi: 10.1097/00042560-199612150-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8970468 Clinical Trial.

5

Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, Schechter MT, O'Shaughnessy MV. Strathdee SA, et al. Among authors: schechter mt. AIDS. 1997 Jul;11(8):F59-65. doi: 10.1097/00002030-199708000-00001. AIDS. 1997. PMID: 9223727

6

Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

Patrick DM, Strathdee SA, Archibald CP, Ofner M, Craib KJ, Cornelisse PG, Schechter MT, Rekart ML, O'Shaughnessy MV. Patrick DM, et al. Among authors: schechter mt. Int J STD AIDS. 1997 Jul;8(7):437-45. doi: 10.1258/0956462971920497. Int J STD AIDS. 1997. PMID: 9228591

7

Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents.

Ostrow MJ, Cornelisse PG, Heath KV, Craib KJ, Schechter MT, O'Shaughnessy M, Montaner JS, Hogg RS. Ostrow MJ, et al. Among authors: schechter mt. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):115-20. doi: 10.1097/00042560-199706010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9241109

8

Physician concurrence with primary care guidelines for persons with HIV disease.

Heath K, Hogg RS, Singer J, Schechter MT, O'Shaughnessy MV, Montaner JS. Heath K, et al. Among authors: schechter mt. Int J STD AIDS. 1997 Oct;8(10):609-13. doi: 10.1258/0956462971918869. Int J STD AIDS. 1997. PMID: 9310219

9

Adherence to clinical guidelines for the therapeutic management of HIV disease.

Heath KV, Hogg RS, Singer J, Schechter MT, O'Shaughnessy MV, Montaner JS. Heath KV, et al. Among authors: schechter mt. Clin Invest Med. 1997 Dec;20(6):381-7. Clin Invest Med. 1997. PMID: 9413635

10

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS. Hogg RS, et al. Among authors: schechter mt. JAMA. 1998 Feb 11;279(6):450-4. doi: 10.1001/jama.279.6.450. JAMA. 1998. PMID: 9466638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters